TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | -1 | 7 | -2 | -8 | -7 | -20 | -5 |
| S | %wins | 80 | 60 | 80 | 60 | 60 | 80 | 70 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/14/14 16:12 | 1/10/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Aberman Zami | L3 | DO | CEO,CB | S.m | -300 | 4.29 | 2 | -70 | -4 | 1,715 | D | 61 | 32 | 43 | 28 | 32 | 33 | 15 | 3 | -1 | -4 | -7 | -22 | -30 | -34 |
1/9/14 18:04 | 1/8/14 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Aberman Zami | L3 | DO | CEO,CB | S.m | -128 | 4.25 | 1 | -30 | -2 | 1,785 | D | 62 | 29 | 37 | 32 | 30 | 25 | 28 | 18 | 0 | 2 | -6 | -11 | -30 | -33 |
8/21/12 16:06 | 8/17/12 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Aberman Zami | L3 | DO | CEO,CB | S | -169 | 5.00 | 7 | -34 | -3 | 1,315 | D | 292 | 63 | 54 | 51 | 58 | 15 | -1 | -7 | -1 | -5 | -1 | -25 | -21 | -24 |
1/20/11 09:47 | 1/18/11 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Aberman Zami | L3 | DO | CEO,CB | S | -80 | 3.20 | 2 | -25 | -3 | 849 | D | 362 | 153 | 153 | 98 | 95 | 87 | 56 | 2 | -13 | 44 | -8 | 1 | 19 | -9 |
1/13/11 08:30 | 1/11/11 | PSTI | Pluristem Therapeutics Inc | NV | Health | BioPrd | Biological Products, (No Diag | Aberman Zami | L3 | DO | CEO,CB | S | -65 | 2.60 | 1 | -25 | -3 | 874 | D | 306 | 122 | 140 | 83 | 90 | 62 | 71 | 42 | 8 | -4 | 11 | 18 | 26 | 2 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |